Gain-of-function mutations in the KCNJ2 gene encoding Kir2.1 are associated with ventricular arrhythmia like short QT syndrome type 3 [13] or atrial arrhythmia such as congenital atrial fibrillation (AF) [14,15]. This evidence concerns the gene KCNJ2 and short QT syndrome type 3.